GRDX
Entero Therapeutics, Inc.
NASDAQ: GRDX · HEALTHCARE · BIOTECHNOLOGY
$2.51
+17.29% today
Updated 2026-04-30
Market cap
$7.56M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-11.66
Dividend yield
—
52W range
$1 – $6
Volume
0.1M
Entero Therapeutics, Inc. (GRDX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
0.00%
ROA
0.00%
Debt/equity
0.01x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2013 | — | $-1014.00 | — | — | — |
| 2014 | — | $-2.37M | — | — | — |
| 2015 | — | $-5.93M | — | — | — |
| 2016 | — | $-14.59M | — | — | — |
| 2017 | — | $-11.10M | — | — | — |
| 2018 | — | $-13.53M | — | — | — |
| 2019 | — | $-15.18M | — | — | — |
| 2020 | — | $-32.67M | — | — | — |
| 2021 | $0.00 | $-58.54M | — | — | — |
| 2022 | $0.00 | $-14.63M | — | — | — |
| 2023 | $0.00 | $-15.79M | — | — | — |
| 2024 | $0.00 | $-18.06M | — | — | — |